<DOC>
	<DOCNO>NCT00334711</DOCNO>
	<brief_summary>The purpose study investigate whether patient diabetes due Kir6.2 mutation treat sulfonylurea medication rather insulin , case investigate mechanism sulfonylurea response .</brief_summary>
	<brief_title>Sulfonylurea Response Patients With Diabetes Due Kir6.2 Mutations</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<criteria>Diabetes due KCNJ11 ( Kir6.2 ) mutation</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2006</verification_date>
	<keyword>Permanent Neonatal Diabetes</keyword>
	<keyword>Kir6.2</keyword>
	<keyword>KCNJ11</keyword>
	<keyword>Infancy onset diabetes</keyword>
	<keyword>Sulfonylurea</keyword>
</DOC>